This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (57)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Andrew N. Phillips, PhD; Jonathan Elford, PhD; Caroline Sabin, MSc; Margaritta Bofill, PhD; George Janossy, DSc; Christine A. Lee, FRCP

JAMA. 1992;268(19):2662-2666.

Abstract
Objective.
—To describe the rate of development of immunodeficiency in human immunodeficiency virus (HIV) infection and to relate this to the risk of death.

Design.
—Inception cohort followed up for up to 12 years from HIV seroconversion until January 1, 1992.

Setting.
—A regional hemophilia center based in a major teaching hospital.

Patients.
—All 111 patients with hemophilia who seroconverted to HIV-1 between 1979 and 1985 were registered at the center. Patients have been closely followed up clinically and immunologically.

Outcome Measures.
—Development of immunodeficiency, defined by a CD4 lymphocyte count falling beneath 0.20 and 0.05 x10⁹/L, and death.

Results.
—Kaplan-Meier estimates suggest that almost half (46%; 95% confidence interval [CI], 26% to 66%) of patients alive 12 years after seroconversion will have a CD4 lymphocyte count that has remained above 0.05 x10⁹/L. Thirty-five percent (95% CI, 22% to 48%) remain above 0.20 x10⁹/L. Thirty-seven patients died of HIV-related causes, and there was a 52% probability (95% CI, 35% to 69%) of HIV-related mortality by 12 years from seroconversion. Mortality risk was closely associated with severe immunodeficiency. There was only a 15% chance (95% CI, 6% to 25%) of HIV-related death occurring before a CD4 count of below 0.05 x 10⁹/L had been reached. There was an average of one HIV-related death per 96.7 patient-years of observation before the CD4 count had fallen below 0.05 x10⁹/L, as compared with one death per 2.5 patient-years of observation after the CD4 count had fallen below this level (P<.0001).

Conclusions.
—In patients with HIV infection who are closely followed up, the risk of death is low before the CD4 lymphocyte count has fallen to 0.05 x 10⁹/L, a count many patients remain above up to 12 years after seroconversion.

(JAMA. 1992;268:2662-2666)

Author Affiliations
From the Academic Department of Genito-Urinary Medicine, University College and Middlesex School of Medicine, London, England (Dr Phillips); and Department of Public Health and Primary Care (Dr Elford and Ms Sabin), Department of Immunology (Dr Bofill and Professor Janossy), and Haemophilia Centre (Dr Lee), Royal Free Hospital and School of Medicine, London, England.

Footnotes
Reprints not available.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Surveillance of HIV in the army of the Republic of Cyprus (SHARC); rationale, design, and implementation of an inexpensive system
Kyriakides et al.
Sex. Transm. Infect. 2002;78:50-52.
ABSTRACT | FULL TEXT  

Health and Federal Budgetary Effects of Increasing Access to Antiretroviral Medications for HIV by Expanding Medicaid
Kahn et al.
AJPH 2001;91:1464-1473.
ABSTRACT | FULL TEXT  

CD4+ T-Lymphocyte Measures in the Treatment of Individuals Infected With Human Immunodeficiency Virus Type 1: A Review for Clinical Practitioners
Turner et al.
Arch Intern Med 1994;154:1561-1573.
ABSTRACT  

Changes in AIDS Survival Time in Two San Francisco Cohorts of Homosexual Men, 1983 to 1993
Osmond et al.
JAMA 1994;271:1083-1087.
ABSTRACT